Here is how AIM ImmunoTech Inc. (AIM) and Cullinan Therapeutics (CGEM) have performed compared to their sector so far this year.
Shares in KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF, FRA:KMSA) rose 7% to 1.42p on Friday after the company responded to speculation around a possible new joint venture in Saudi Arabia. The AIM-quoted precious metals group, which is in the mine construction phase in Ethiopia, said its Saudi Gold and Minerals SLA (known as GMCO), in which it holds a 13% stake, is working with local conglomerate AJ Lan Group on a potential deal.
Artemis Resources Ltd (ASX:ARV, AIM:ARV, OTCQB:ARTTF, FRA:ATY) shares dropped around 20% on Thursday after it announced the cancellation of its AIM market admission, effective from 13 February 2026. The decision follows a review of the costs and benefits of maintaining the dual listing.
Here is how AIM ImmunoTech Inc. (AIM) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.
Shares in Directa Plus PLC (AIM:DCTA, OTC:DTPKF) fell 23% to 10.44p after the AIM-listed graphene specialist flagged a sharp drop in cash and warned that fresh funding will be needed to support growth in 2026. The company said it expects full-year revenues of €7.0 million, up modestly from €6.66 million last year, with an adjusted loss before interest, tax, depreciation and amortisation of about €2.5 million.
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF) said on Tuesday its shares began trading on the AIM market of the London Stock Exchange, expanding the energy company's access to international investors following a recent acquisition. Dealings in Sintana's common shares, represented by depositary interests, started at 8 AM GMT under the ticker “SEI”, giving the company an expected market capitalisation of about £128 million, it said.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) said it expects to complete the full financing package for its flagship Tulu Kapi gold project in Ethiopia this month, after confirming it has signed a term sheet for $30 million of new funding. The AIM-listed miner moved to clarify recent media speculation by saying the funding would take the form of so-called gold streams, a specialist type of finance commonly used in the mining sector.
Shares in Ariana Resources PLC (AIM:AAU, ASX:AA2) rose 9% to 1.5p after the miner unveiled a binding agreement with a Chinese mining services group that will inject an initial A$8 million into the business and help fund key technical work at its Dokwe gold project in Zimbabwe. The AIM-quoted company said the deal marks a significant step towards completing a definitive feasibility study at Dokwe, which it owns outright, while also bringing in a long-term strategic partner.
Ariana Resources PLC (AIM:AAU, ASX:AA2) has struck a binding deal with a Chinese mining services group that will inject an initial A$8 million of fresh cash into the company and fund key technical work on its Dokwe gold project in Zimbabwe. The AIM-quoted miner said the agreement marks an important step towards completing a full feasibility study at Dokwe, which it owns outright, and brings a strategic partner onto the register.
Sintana Energy Inc said on Thursday it has published an admission document for the listing of its shares on London's AIM market, with trading expected to begin on December 23, marking a further step in the company's expansion following its recent acquisition of Challenger Energy Group. The Canada-based oil and gas explorer said its common shares, represented by depositary interests, will trade on AIM while continuing to be listed on the TSX Venture Exchange in Canada and the OTCQX market in the US.
Fatigue remains a stubborn danger for lorry and bus drivers around the world, according to new data from Seeing Machines Ltd (AIM:SEE, OTC:SEEMF), the AIM-listed technology group that supplies in-cab monitoring systems for commercial fleets. The company's latest Guardian Insights Report, drawn from about 60,000 vehicles fitted with its equipment, analysed more than 3 million verified risky driving events across 3.7 billion kilometres travelled between October 2024 and September 2025.
CelLBxHealth PLC (AIM:CLBX, OTCQB:ANPCF) has wrapped up its latest retail fundraise, bringing in about £960,000 as part of a wider financing package designed to support the diagnostics company's plans to scale. The AIM-quoted group, which focuses on analysing circulating tumour cells, cancer cells that break away from a tumour and enter the bloodstream, said the retail offer launched last week is now closed.